American Diabetes Association Highlights Novel Agent Retatrutide which Results in Substantial Weight Reduction in People with Obesity or Type 2 Diabetes During Late Breaking Symposium
Today, findings from two phase 2 clinical trials showcase new data for an investigational, once-weekly injectable glucose-dependent…Read more